643 related articles for article (PubMed ID: 30498750)
1. Breast cancer stem cells and the challenges of eradication: a review of novel therapies.
Saeg F; Anbalagan M
Stem Cell Investig; 2018; 5():39. PubMed ID: 30498750
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
[TBL] [Abstract][Full Text] [Related]
3. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications.
Ordaz-Ramos A; Tellez-Jimenez O; Vazquez-Santillan K
Front Cell Dev Biol; 2023; 11():1221175. PubMed ID: 37492224
[TBL] [Abstract][Full Text] [Related]
4. Are breast cancer stem cells the key to resolving clinical issues in breast cancer therapy?
Shima H; Yamada A; Ishikawa T; Endo I
Gland Surg; 2017 Feb; 6(1):82-88. PubMed ID: 28210556
[TBL] [Abstract][Full Text] [Related]
5. Targeting breast cancer stem cells through retinoids: A new hope for treatment.
Jan N; Sofi S; Qayoom H; Haq BU; Shabir A; Mir MA
Crit Rev Oncol Hematol; 2023 Dec; 192():104156. PubMed ID: 37827439
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem cells and tumorigenesis.
Zhu P; Fan Z
Biophys Rep; 2018; 4(4):178-188. PubMed ID: 30310855
[TBL] [Abstract][Full Text] [Related]
7. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence.
Aramini B; Masciale V; Grisendi G; Bertolini F; Maur M; Guaitoli G; Chrystel I; Morandi U; Stella F; Dominici M; Haider KH
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205721
[TBL] [Abstract][Full Text] [Related]
8. Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt β-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4.
Bhuvanalakshmi G; Basappa ; Rangappa KS; Dharmarajan A; Sethi G; Kumar AP; Warrier S
Front Pharmacol; 2017; 8():124. PubMed ID: 28373842
[No Abstract] [Full Text] [Related]
9. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
Safa AR
Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
[TBL] [Abstract][Full Text] [Related]
10. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
Katoh M
Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer stem cells, pathways and therapeutic perspectives 2011.
Nigam A
Indian J Surg; 2013 Jun; 75(3):170-80. PubMed ID: 24426422
[TBL] [Abstract][Full Text] [Related]
12. Deciphering Potential Role of Hippo Signaling Pathway in Breast Cancer: A Comprehensive Review.
Bhavnagari H; Raval A; Shah F
Curr Pharm Des; 2023; 29(44):3505-3518. PubMed ID: 38141194
[TBL] [Abstract][Full Text] [Related]
13. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
[TBL] [Abstract][Full Text] [Related]
14. Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells.
Chanmee T; Ontong P; Kimata K; Itano N
Front Oncol; 2015; 5():180. PubMed ID: 26322272
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Strategies Against Cancer Stem Cells in Esophageal Carcinomas.
Das PK; Islam F; Smith RA; Lam AK
Front Oncol; 2020; 10():598957. PubMed ID: 33665161
[TBL] [Abstract][Full Text] [Related]
16. Esophageal cancer stem cells and implications for future therapeutics.
Qian X; Tan C; Wang F; Yang B; Ge Y; Guan Z; Cai J
Onco Targets Ther; 2016; 9():2247-54. PubMed ID: 27143920
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
[TBL] [Abstract][Full Text] [Related]
19. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs.
Zhao Q; Zong H; Zhu P; Su C; Tang W; Chen Z; Jin S
Exp Hematol Oncol; 2024 Jan; 13(1):6. PubMed ID: 38254219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
